Cargando…
Hypersensitivity reactions to biologics used in the treatment of allergic diseases: clinical features, diagnosis and management
Several monoclonal antibodies have been approved by the Food and Drug Administration (FDA) to treat allergic disorders, including omalizumab, dupilumab, mepolizumab, reslizumab, benralizumab, tralokinumab and tezepelumab, and their indications continue to expand. Although the risks associated with t...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450930/ https://www.ncbi.nlm.nih.gov/pubmed/37637139 http://dx.doi.org/10.3389/falgy.2023.1219735 |